Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2023 | 3 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
SARS-CoV-2 vaccine-induced antibodies protect against Omicron breakthrough infection.
iScience. 2023 Aug 14;26(9):107621. doi: 10.1016/j.isci.2023.107621. eCollection 2023 Sep 15.
iScience. 2023.
PMID: 37682631
Free PMC article.
Impact of age and comorbidities on SARS-CoV-2 vaccine-induced T cell immunity.
Dietz LL, Juhl AK, Søgaard OS, Reekie J, Nielsen H, Johansen IS, Benfield T, Wiese L, Stærke NB, Jensen TØ, Jakobsen SF, Olesen R, Iversen K, Fogh K, Bodilsen J, Petersen KT, Larsen L, Madsen LW, Lindvig SO, Holden IK, Raben D, Andersen SD, Hvidt AK, Andreasen SR, Baerends EAM, Lundgren J, Østergaard L, Tolstrup M; ENFORCE Study Group.
Dietz LL, et al.
Commun Med (Lond). 2023 Apr 24;3(1):58. doi: 10.1038/s43856-023-00277-x.
Commun Med (Lond). 2023.
PMID: 37095240
Free PMC article.
Item in Clipboard
Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial.
ACTIV-3/Therapeutics for Inpatients with COVID-19 (TICO) Study Group.
ACTIV-3/Therapeutics for Inpatients with COVID-19 (TICO) Study Group.
Lancet Infect Dis. 2022 May;22(5):622-635. doi: 10.1016/S1473-3099(21)00751-9. Epub 2021 Dec 23.
Lancet Infect Dis. 2022.
PMID: 34953520
Free PMC article.
Clinical Trial.
Item in Clipboard
Association of Self-reported Systemic Reactions Following SARS-CoV-2 Vaccination With Immunological Response in the Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 Vaccines (ENFORCE).
Bannister WP, Raben D, Valentiner-Branth P, Tolstrup M, Larsen L, Tarp B, Brouw Iversen M, Schmeltz Søgaard O, Rye Ostrowski S, Breinholt Stærke N, Jakobsen ML, Olaf Lindvig S, Ruwald Juhl M, Somuncu Johansen I, Mustafa AB, Østergaard L, Dam Larsen F, Surland Knudsen L, Klastrup V, Wiese L, Benfield T, Toft Petersen K, Iversen KK, Nielsen H, Reekie J, Lundgren J; ENFORCE Study Group.
Bannister WP, et al.
Open Forum Infect Dis. 2023 May 8;10(6):ofad248. doi: 10.1093/ofid/ofad248. eCollection 2023 Jun.
Open Forum Infect Dis. 2023.
PMID: 37351453
Free PMC article.
Item in Clipboard
Cite
Cite